David Klank - Publications

MRI and Ultrasound in giant cell arteritis: complementary strengths and combined diagnostic value.

Journal: Seminars in arthritis and rheumatism

Published: January 31, 2026

Treatment of Lung Cancer Patients 2016-2022: Increased Use of Therapies Including Checkpoint Inhibitors

Journal: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))

Published: July 30, 2025

Impact of Kidney Histology and Choice of Treatment on Survival in Patients with Multiple Myeloma.

Journal: Kidney360

Published: July 30, 2025

New versus old: comparison of the 2022 ACR/EULAR versus the 1990 ACR classification criteria for giant cell arteritis in a real-world cohort.

Journal: Rheumatology international

Published: April 04, 2025

The Urine Light Chain/eGFR Quotient as a Tool to Rule out Cast Nephropathy in Myeloma-Associated Kidney Failure.

Journal: Biomedicines

Published: April 07, 2024

Clinical and histological comparison of IgA nephritis and renal IgA vasculitis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: December 20, 2023

Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19.

Journal: Microorganisms

Published: November 20, 2022

Histological Findings in Kidney Biopsies of Patients with Monoclonal Gammopathy-Always a Surprise.

Journal: Diagnostics (Basel, Switzerland)

Published: July 13, 2022

Monoclonal Antibodies for the Prevention and Treatment of COVID-19 Disease in Patients With Hematological Malignancies: Two Case Reports and a Literature Review.

Journal: HemaSphere

Published: June 23, 2021

The urine light chain/glomerular filtration rate (GFR) quotient shows a high sensitivity and specificity to detect cast nephropathy in monoclonal light chain disease.

Journal: European journal of haematology

Published: November 22, 2020